Chromis Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12760 High Bluff Dr Ste 370, San Diego, ...Website
www.chromistherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Chromis Therapeutics
Chromis Therapeutics, Inc. is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. The company is seeking investment to advance its novel cccDNA inhibitor (CHR101), viral entry and viral capsid assembly inhibitor lead candidates for the treatment of chronic HBV. CHR101 has the potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. CHR101's activity is supported by a robust discovery preclinical data package.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chromis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Chromis Therapeutics is spiking on competitors!
Check if Chromis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Chromis Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Chromis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Chromis Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Chromis Therapeutics
Earning: See what the market has to say on Chromis Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Chromis Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Chromis Therapeutics
Compare insights from companies similar to Chromis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Chromis Therapeutics
<$5M
11-50
Private
<$5M
2016
N/A
Company Profile Activity
Activity Insights
Chromis Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chromis Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chromis Therapeutics.
Chromis Therapeutics financials insights
Gather financial insights about Chromis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$3M
Chromis Therapeutics Tech Stack
A closer look at the technologies used by Chromis Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chromis Therapeutics
Sign Up For FreeTo access detailed company insights
Chromis Therapeutics, Inc. is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. The company is seeking investment to advance its novel cccDNA inhibitor (CHR101), viral entry and viral capsid assembly inhibito... Read More
